insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.

사설/논평 0/5 보강
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 📖 저널 OA 34.8% 2022: 4/6 OA 2024: 4/10 OA 2025: 30/61 OA 2026: 38/143 OA 2022~2026 2026 Vol.44(3) p. 256-257 OA
Retraction 확인
출처
PubMed DOI PMC

Sharman JP, Liu B, Wang DY, Leow CC, Barr PM

📖 무료 전문 🟢 PMC 전문 PMC12794705 🔓 OA PDF unpaywall · cc-by-nc-nd
PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris
APA Sharman JP, Liu B, et al. (2026). Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(3), 256-257. https://doi.org/10.1200/JCO-25-02231
MLA Sharman JP, et al.. "Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 44, no. 3, 2026, pp. 256-257.
PMID 41270260 ↗
DOI 10.1200/JCO-25-02231

같은 제1저자의 인용 많은 논문 (1)

🟢 PMC 전문 열기